MALAT1 and nasopharyngeal carcinoma: Analysis of the efficacy in other types manifested that MALAT-1 testing harvested an AUC of 0.84, specificity of 0.88 and DOR of 11.33 in identifying nasopharyngeal carcinoma, suggesting that MALAT-1 might be developed as a promising biomarker for nasopharyngeal carcinoma as well.